The Centre officially confirms the presence of the JN.1 subvariant of Covid-19 in a patient from Kerala, marking India's first case. The variant is closely linked to the BA.2.86, known as Pirola, detected in the US and China. The patient from Thiruvananthapuram, who tested positive on December 8, has recovered. Kerala experiences a surge in Covid cases, with a majority being mild. A health ministry mock drill assesses preparedness, while experts suggest exploring the role of JN.1. The subvariant, first detected in the US, raises questions about its transmissibility and immune evasion.

Singapore experiences a spike in Covid-19 cases, reaching 56,043 in the week of December 3 to 9, compared to 32,035 the previous week. The Health Ministry reinstates mask advisories in crowded places and urges precautions for travelers. Average daily hospitalizations and ICU cases rise, prompting additional measures to safeguard healthcare capacity. The dominant strain, JN.1, raises concerns, but no clear evidence of increased transmissibility or severity. Singapore emphasizes vaccination's crucial role, urging public cooperation. Daily updates on Covid-19 cases will be available on the Health Ministry's website from December 19, 2023. 

The Union Ministry of Health has activated preparedness measures following the identification of the JN.1 subvariant of COVID in Kerala during routine surveillance by the Indian SARS-CoV-2 Genomics Consortium. Dr. Rajiv Bahl, Director-General of the Indian Council of Medical Research, confirmed the case, prompting a nationwide mock drill to assess public health readiness. While cases in Kerala remain mostly mild, health authorities stress the importance of ongoing vigilance. The JN.1 subvariant, initially detected in the United States in September 2023, exhibits upper respiratory symptoms. Medical experts advise vigilance without panic as the situation evolves.

Tamil Nadu gears up to tackle a potential COVID-19 outbreak following a spike in cases in neighboring Kerala and in Singapore. Health Minister Ma. Subramanian instructs officials to implement preventive measures, conduct RT-PCR tests for increased fever cases, and closely monitors the situation. Kerala reports a case of the JN.1 subvariant, emphasizing a growing trend in infections. Tamil Nadu maintains 36 active cases with a 98.94% discharge rate. Health authorities are in contact with Kerala counterparts, and a mock drill assesses public health preparedness. The Union Health Ministry coordinates efforts to monitor points of entry.

As Singapore witnesses a 75% spike in COVID-19 cases, the Ministry of Health strongly encourages mask-wearing in crowded places, irrespective of health status. The surge, with 56,043 cases from Dec 3 to 9, sees average daily hospitalizations rising from 225 to 350. The intensive care unit reports an increase from four to nine daily cases. Predominantly, the JN.1 variant is responsible. The Ministry emphasizes personal and social responsibility, urging unwell individuals to stay home and advising travelers to wear masks, obtain travel insurance, and avoid poorly ventilated crowded areas.

The detection of the JN.1 COVID subvariant in Kerala sparks worries, with a case found in a 79-year-old woman. Originating from the United States in September 2023, JN.1, a descendant of BA.2.86, raises concerns about its impact. The patient, with mild influenza-like symptoms, had recovered from COVID-19. While an Indian traveler also tested positive in Singapore, there's no surge in cases reported. Surveillance by INSACOG assures vigilance, with expert Rajeev Jayadevan noting JN.1's fast spread and immune evasion. China reports seven cases, emphasizing the need for caution amid rising COVID infections in India.

The UK reports a surge in norovirus cases, with almost 1,500 confirmed infections, marking a 60% increase from the same period last year. The Royal College of Emergency Medicine Scotland warns of heightened risks of staff sickness, straining hospital resources. Commonly known as the "winter vomiting bug," norovirus causes nausea, vomiting, and diarrhea. Health experts express concerns about the rising numbers of norovirus and other winter illnesses as the Christmas season approaches. Norovirus is highly contagious, spreading easily through contact, and there is no specific vaccine for it. Authorities emphasize hygiene practices to curb the virus's transmission.

Amid a surge in respiratory infections, Southeast Asian governments are re-imposing preventive measures to curb the spread. Singapore has mandated mask-wearing at airports and implemented temperature scanners. The Ministry of Health cites factors like waning immunity and increased year-end travel. In Indonesia, citizens are urged to delay travel, complete vaccinations, and adhere to safety protocols. Malaysia reports a doubling of COVID-19 cases but assures control. Tensions rise as fears of drastic measures return, countered by officials dispelling misinformation. The emergence of JN.1 variant raises concerns globally. Governments intensify efforts to curb transmission and protect healthcare systems. [Representative Image]

Union Minister Smriti Irani stated in Parliament that menstruation is not a "handicap" necessitating mandatory paid leave policies for workplaces. Responding to questions on India's menstrual hygiene provisions, Irani said most menstrual difficulties are medically manageable without denying women equal opportunities. The government recently released a draft Menstrual Hygiene Policy advocating flexible work arrangements during periods to promote inclusivity. However, Irani emphasized such support systems should be available to all rather than perpetuate assumptions about productivity. Highlighting affordable sanitary napkin access and disposal protocols, she detailed awareness schemes like the NHM-backed Promotion of Menstrual Hygiene targeting adolescent girls.

Health officials in the UK issued a warning about a highly infectious bacterial disease called "100-day cough" that is rapidly spreading, with cases up 250% between July and November. The infection, also known as pertussis or whooping cough, begins with cold-like symptoms but progresses to prolonged, intense coughing bouts lasting up to three months. Dr. Gayatri Amirthalingam of the UK Health Security Agency said infections decreased during the pandemic due to social distancing but are surging again, with 716 reported cases recently compared to 236 last year. The painful cough can make breathing difficult and lead to vomiting, sore ribs, or fractures. The NHS says the preventable disease can be protected against with a readily available vaccine, especially for vulnerable children and babies.